SueWallSt

Hundreds of securities fraud lawsuits hit the courts every year—yet most investors find out too late. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Anna and Nate break down exactly how to stay ahead of the curve. This one’s for retail investors, finance enthusiasts, and anyone holding public equities. Learn how to use SEC alerts, shareholder notices, and free portfolio monitoring tools to detect fraud early. Expect sharp insights, casual banter, and practical tips.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

What happens when a company chooses profits over principles? In this episode of Sue Wall Street, Cassie and Bill dive into the ethical wreckage left behind by securities fraud. It's not just about breaking the law—it’s about breaking trust with investors, employees, and the public. If you're holding $stock in any NYSE or NASDAQ company, this episode’s your reality check on why integrity should matter just as much as earnings.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Ever scrolled past a “You may be entitled to compensation” ad and thought it was spam? It might be your money. In this episode of Sue Wall Street, Cassie and Bill break down how to know if you qualify for a securities fraud class action—no suit, no courtroom, just checking your trade history. If you've ever owned $stock through a brokerage, app, or retirement account, you could be owed cash.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

What happens when a company lies—and your retirement, tuition fund, or nest egg disappears overnight? In this emotional episode of Sue Wall Street, Cassie and Bill explore the real-life consequences of securities fraud, from retirees losing 401(k)s to parents watching college dreams vanish. If you own $stocks through a 401k, IRA, or mutual fund, this one's for you.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

If your favorite $stock tanks after suspicious news breaks, you might already be part of a securities fraud class action and not even know it. In this episode of Sue Wall Street, Cassie and Bill break down how these lawsuits work, what counts as fraud, and how you could get compensation—no courtroom drama required. Perfect for retail investors, market-watchers, or anyone who's ever asked, “Wait… can I sue for that?”

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

You don’t need to be a billionaire to bring a securities fraud case—just a regular investor with skin in the game. In this episode of Sue Wall Street, Cassie and Bill unpack how everyday shareholders become lead plaintiffs in securities class actions. Learn how fraud gets exposed, how claims get paid, and how you can turn a bad stock loss into real accountability. If you own stock on the NYSE or NASDAQ, this one’s for you.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Ever wonder why giant class action lawsuits—like those against $XYZ—almost never go to trial? In this episode of Sue Wall Street, Cassie and Bill pull back the curtain on how and why securities fraud cases settle behind closed doors. If you're an investor, shareholder, or just securities-curious, this episode breaks down the strategy, the money, and the silence that drives multi-million-dollar settlements. Expect witty banter, sharp insights, and a crash course in legal chess.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

This episode of Sue Wall Street dives deep into the class action lawsuit against Sarepta Therapeutics $SRPT. From FDA fast-tracking to tragic deaths linked to its Duchenne drug ELEVIDYS, investors are alleging massive corporate deception. If you're an investor, biotech enthusiast, or anyone tracking Wall Street accountability, this one’s for you. Expect raw details, lawsuit breakdowns, and sharp commentary.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Visit ZLK.com for more info.

Novo Nordisk Drops Bombshell in Knockoff Drug Scandal

Was $HIMS pushing fake weight-loss meds? This episode of Sue Wall Street unpacks the explosive class action against Hims & Hers Health after Novo Nordisk cut ties, accusing them of selling unauthorized semaglutide. We break down the lawsuit, the FDA compliance issues, and the stock’s 34% crash. Perfect for retail investors, financial watchdogs, and Wall Street skeptics. Expect legal drama, corporate accountability, and deep dives into public health risk and securities fraud.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

3D Systems $DDD promised 3D-printed lungs. Then the stock dropped nearly 50%. In this episode of Sue Wall Street: Holding Wall Street Accountable, Cassie and Bill break down a wild securities class action involving futuristic biotech, shifting revenue milestones, and massive shareholder losses. Perfect for retail investors, finance buffs, and anyone watching the intersection of innovation and accountability. Expect sharp commentary, real case facts, and a splash of humor.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.